Tech Company Financing Transactions
Nexo Therapeutics Funding Round
Versant Ventures, Cormorant Asset Management and New Enterprise Associates joined a $60 million Series A capital raise for Nexo Therapeutics. This venture round was announced on 7/27/2023.
Transaction Overview
Company Name
Announced On
7/27/2023
Transaction Type
Venture Equity
Amount
$60,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to expand the platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11757 W. Ken Caryl Avenue F, 520
Littleton, CO 80127
USA
Littleton, CO 80127
USA
Phone
Undisclosed
Website
Email Address
Overview
In many disease areas biology has identified the most compelling drug targets. The vast majority of these targets are elusive to drug discovery for two primary reasons: 1. there are no quality ligands for the target, and 2. there is a limited understanding of the pharmacology (how hard, how long) required to effectively modulate the target.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrew Phillips
Chief Operating Officer
Michael Kim
Co-Founder
Rhamy Zeid
Browse more venture capital transactions:
Prev: 7/27/2023: Low Carbon venture capital transaction
Next: 7/27/2023: Iventis venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs